The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.
Some large-cap stocks are past their peak, and StockStory is here to help you separate the winners from the laggards. That said, here is one S&P 500 stock that is leading the market forward and two that may struggle.
Two Stocks to Sell:
Snap-on (SNA)
Market Cap: $21.67 billion
Founded in 1920, Snap-on (NYSE: SNA) is a global provider of tools, equipment, and diagnostics for various industries such as vehicle repair, aerospace, and the military.
Why Are We Hesitant About SNA?
- Core business is underperforming as its organic revenue has disappointed over the past two years, suggesting it might need acquisitions to stimulate growth
- Earnings per share were flat over the last two years and fell short of the peer group average
- Waning returns on capital imply its previous profit engines are losing steam
Snap-on’s stock price of $430.23 implies a valuation ratio of 20.2x forward P/E. Dive into our free research report to see why there are better opportunities than SNA.
MSCI (MSCI)
Market Cap: $41.57 billion
Originally known as Morgan Stanley Capital International before becoming independent in 2007, MSCI (NYSE: MSCI) provides critical decision support tools, indexes, and analytics that help global investors understand risk and return factors and build more effective investment portfolios.
Why Is MSCI Not Exciting?
- Negative return on equity shows management lost money while trying to expand the business
At $571.81 per share, MSCI trades at 27x forward P/E. To fully understand why you should be careful with MSCI, check out our full research report (it’s free).
One Stock to Watch:
Cigna (CI)
Market Cap: $71.48 billion
With roots dating back to 1792 and serving millions of customers across the globe, The Cigna Group (NYSE: CI) provides healthcare services through its Evernorth Health Services and Cigna Healthcare segments, offering pharmacy benefits, specialty care, and medical plans.
Why Does CI Stand Out?
- Solid 13.8% annual revenue growth over the last two years indicates its offerings solve complex business issues
- Unparalleled scale of $282.1 billion in revenue enables it to spread administrative costs across a larger membership base
- Earnings growth has easily exceeded the peer group average over the last five years as its EPS has compounded at 12% annually
Cigna is trading at $270.00 per share, or 8.6x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.
